THE PHARMACOKINETICS OF D-SOTALOL AND D,L-SOTALOL IN HEALTHY-VOLUNTEERS

被引:36
作者
POIRIER, JM
JAILLON, P
LECOCQ, B
LECOCQ, V
FERRY, A
CHEYMOL, G
机构
[1] HOP ST ANTOINE,UNITE PHARMACOL CLIN,184 RUE FAUBOURG ST ANTOINE,F-75571 PARIS 12,FRANCE
[2] HOP ST ANTOINE,PHARMACOL LAB,F-75571 PARIS 12,FRANCE
关键词
d; l-sotalol; d-sotalol; healthy volunteers; pharmacokinetics;
D O I
10.1007/BF00278585
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of d-sotalol has been studied in six healthy volunteers given single doses of 0.25, 0.50, 1, 2 mg·kg-1 i.v. and one 100 mg oral dose in comparison with the kinetics of 1 mg·kg-1 i.v. of dlsotalol. There was no significant difference in the disposition of the d-enantiomer and the racemate. The terminal half-life averaged 7.2 h, and the kinetics was linear, with a mean total clearance of 0.13 l·h-1·kg-1. Renal clearance of d-sotalol represented 56 to 77% of total clearance. The absolute systemic availability of oral d-sotalol was close to 100% and the elimination half-life of the oral-d-enantiomer was similar to that of the i.v. form (7.5 h). © 1990 Springer-Verlag.
引用
收藏
页码:579 / 582
页数:4
相关论文
共 27 条
[1]   STEREOSELECTIVE BINDING OF PROPRANOLOL ENANTIOMERS TO HUMAN ALPHA-1-ACID GLYCOPROTEIN AND HUMAN-PLASMA [J].
ALBANI, F ;
RIVA, R ;
CONTIN, M ;
BARUZZI, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (02) :244-246
[2]  
ANTTILA M, 1976, ACTA PHARMACOL TOX, V39, P118
[3]  
BENNETT DH, 1982, BRIT HEART J, V47, P521
[4]  
DATHIS P, THESIS FM CHU DIJON
[5]  
DUMOULIN P, 1985, ARCH MAL COEUR VAISS, V78, P562
[6]  
ECHT DS, 1982, AM J CARDIOL, V50, P1082, DOI 10.1016/0002-9149(82)90421-0
[7]  
Edvardsson N, 1980, Eur Heart J, V1, P335
[8]   PHARMACOKINETICS OF (+)-VERAPAMIL, (-)-VERAPAMIL AND (+/-)-VERAPAMIL AFTER INTRAVENOUS ADMINISTRATION [J].
EICHELBAUM, M ;
MIKUS, G ;
VOGELGESANG, B .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (04) :453-458
[9]  
FOURTILLAN JB, 1981, THERAPIE, V36, P457
[10]  
ISHIZAKI T, 1980, J PHARMACOL EXP THER, V212, P173